Literature DB >> 15238432

Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation.

Carrie Ann Mohila1, Shao-Pii Onn.   

Abstract

We previously reported synchronization of pyramidal neurons within prefrontal cortex of rats repeatedly exposed to amphetamine (AMPH). To test the hypothesis that cortical synchronization may be related to changes in local GABA signaling, we used antibodies specific for parvalbumin (PV), calbindin D28k (CB) and calretinin (CR) as selective labels for three distinct GABA interneuron classes in the anterior cingulate cortex (ACC) of similarly treated rats. We observed a selective increase in the density of PV-immunoreactive (ir), but not CB-ir or CR-ir, neurons in the ACC of AMPH-treated rats at both 1 day and 7 day withdrawal. Increased density of PV-ir GABA interneurons in the ACC at 1 day withdrawal was reproduced in rats repeatedly injected with apomorphine or with SKF-38393. Thus, the critical role of DA receptors during AMPH exposure is evident. However, DA receptor activation did not appear to account for the PV up-regulation in AMPH-treated rats at 7 day withdrawal. Significantly higher numbers of pericellular basket-like puncta immunoreactive for corticotropin-releasing factor (CRF) were observed in the ACC of AMPH rats at 7 day withdrawal. Combined dual immunofluorescence and confocal microscopy further revealed that CRF-ir puncta made possible pericellular contacts on PV-ir (not CB-, CR- or glutamate-ir) cell bodies. A potential cellular mechanism seems to emerge that CRF-ir terminals, that may be underdetected under normal conditions due to low activity levels, may be functionally activated during psychostimulant withdrawal, thereby altering local GABAergic signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238432     DOI: 10.1093/cercor/bhh128

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  7 in total

1.  Working Memory Impairing Actions of Corticotropin-Releasing Factor (CRF) Neurotransmission in the Prefrontal Cortex.

Authors:  Sofiya Hupalo; Craig W Berridge
Journal:  Neuropsychopharmacology       Date:  2016-06-08       Impact factor: 7.853

2.  Prefrontal Corticotropin-Releasing Factor (CRF) Neurons Act Locally to Modulate Frontostriatal Cognition and Circuit Function.

Authors:  Sofiya Hupalo; Andrea J Martin; Rebecca K Green; David M Devilbiss; Craig W Berridge
Journal:  J Neurosci       Date:  2019-01-16       Impact factor: 6.167

Review 3.  Corticotropin-Releasing Factor (CRF) circuit modulation of cognition and motivation.

Authors:  Sofiya Hupalo; Courtney A Bryce; Debra A Bangasser; Craig W Berridge; Rita J Valentino; Stan B Floresco
Journal:  Neurosci Biobehav Rev       Date:  2019-06-15       Impact factor: 8.989

4.  Differential activation of neuronal cell types in the basolateral amygdala by corticotropin releasing factor.

Authors:  Amanda B Rostkowski; Randy J Leitermann; Janice H Urban
Journal:  Neuropeptides       Date:  2013-05-18       Impact factor: 3.286

Review 5.  [Structural and functional brain changes in schizophrenic disorders. Indications of early neuronal developmental disturbances?].

Authors:  P Kalus; P Falkai; A Heinz
Journal:  Nervenarzt       Date:  2008-03       Impact factor: 1.214

6.  Age- and sex-dependent effects of methamphetamine on cognitive flexibility and 5-HT2C receptor localization in the orbitofrontal cortex of Sprague-Dawley rats.

Authors:  Emily R Hankosky; Sara R Westbrook; Rachel M Haake; Jari Willing; Lori T Raetzman; Janice M Juraska; Joshua M Gulley
Journal:  Behav Brain Res       Date:  2018-04-30       Impact factor: 3.332

7.  The effect of self-administered methamphetamine on GABAergic interneuron populations and functional connectivity of the nucleus accumbens and prefrontal cortex.

Authors:  Katherine J Robinson; Nicholas A Everett; Sarah J Baracz; Jennifer L Cornish
Journal:  Psychopharmacology (Berl)       Date:  2022-08-03       Impact factor: 4.415

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.